Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes.
acetylation
cardiac hypertrophy
heart failure
mitochondrial antioxidant
mitochondrial dysfunction
mitophagy
oxidative stress
superoxide dismutase 2
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
06 Apr 2022
06 Apr 2022
Historique:
received:
03
03
2022
revised:
30
03
2022
accepted:
04
04
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
Heart failure, mostly associated with cardiac hypertrophy, is a major cause of illness and death. Oxidative stress causes accumulation of reactive oxygen species (ROS), leading to mitochondrial dysfunction, suggesting that mitochondria-targeted therapies could be effective in this context. The purpose of this work was to determine whether mitochondria-targeted therapies could improve cardiac hypertrophy induced by mitochondrial ROS. We used neonatal (NCMs) and adult (ACMs) rat cardiomyocytes hypertrophied by isoproterenol (Iso) to induce mitochondrial ROS. A decreased interaction between sirtuin 3 and superoxide dismutase 2 (SOD2) induced SOD2 acetylation on lysine 68 and inactivation, leading to mitochondrial oxidative stress and dysfunction and hypertrophy after 24 h of Iso treatment. To counteract these mechanisms, we evaluated the impact of the mitochondria-targeted antioxidant mitoquinone (MitoQ). MitoQ decreased mitochondrial ROS and hypertrophy in Iso-treated NCMs and ACMs but altered mitochondrial structure and function by decreasing mitochondrial respiration and mitophagy. The same decrease in mitophagy was found in human cardiomyocytes but not in fibroblasts, suggesting a cardiomyocyte-specific deleterious effect of MitoQ. Our data showed the importance of mitochondrial oxidative stress in the development of cardiomyocyte hypertrophy. We observed that targeting mitochondria by MitoQ in cardiomyocytes impaired the metabolism through defective mitophagy, leading to accumulation of deficient mitochondria.
Identifiants
pubmed: 35453408
pii: antiox11040723
doi: 10.3390/antiox11040723
pmc: PMC9029275
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Agence Nationale de la Recherche
ID : ANR-16-RHUS-0003
Références
Free Radic Biol Med. 2015 Aug;85:114-26
pubmed: 25908444
Eur Heart J. 2011 Jan;32(1):115-23
pubmed: 20418543
Mol Aspects Med. 2020 Feb;71:100822
pubmed: 31587811
Expert Rev Cardiovasc Ther. 2016 Dec;14(12):1305-1313
pubmed: 27758146
Circ Heart Fail. 2018 Jun;11(6):e004838
pubmed: 29891738
PLoS One. 2016 Dec 28;11(12):e0168283
pubmed: 28030582
Circ Res. 2017 Feb 17;120(4):645-657
pubmed: 28096195
Front Physiol. 2021 Jun 30;12:700585
pubmed: 34276422
Cell Metab. 2017 Dec 5;26(6):872-883.e5
pubmed: 29107503
Physiol Rep. 2018 Apr;6(7):e13667
pubmed: 29611340
Cells. 2022 Jan 07;11(2):
pubmed: 35053316
J Mol Cell Cardiol. 2012 Mar;52(3):660-6
pubmed: 22155238
Antioxid Redox Signal. 2007 Nov;9(11):1825-36
pubmed: 17854275
Oxid Med Cell Longev. 2018 Apr 11;2018:4079041
pubmed: 29849892
J Biol Chem. 2010 Mar 12;285(11):8375-82
pubmed: 20089851
Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H239-50
pubmed: 16489105
Free Radic Biol Med. 2005 Jun 1;38(11):1458-70
pubmed: 15890620
Redox Biol. 2020 Oct;37:101740
pubmed: 33049519
Am J Physiol Heart Circ Physiol. 2020 Mar 1;318(3):H682-H695
pubmed: 32004065
Int J Cardiol. 2018 Sep 1;266:198-205
pubmed: 29887448
Cells. 2020 Feb 17;9(2):
pubmed: 32079154
Circ Res. 2001 Mar 16;88(5):529-35
pubmed: 11249877
Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1066-1077
pubmed: 27836629
Br J Pharmacol. 2018 Apr;175(8):1126-1145
pubmed: 28503736
Cardiovasc Res. 2009 Feb 15;81(3):449-56
pubmed: 18854381
Int J Mol Sci. 2018 Aug 31;19(9):
pubmed: 30200365
Nutrients. 2019 Sep 04;11(9):
pubmed: 31487802
Circulation. 1985 Aug;72(2):406-12
pubmed: 3891136
Sci Rep. 2012;2:1002
pubmed: 23256036
Circulation. 1997 Mar 4;95(5):1314-9
pubmed: 9054865
Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1682-1698
pubmed: 31189433
Biochim Biophys Acta Mol Basis Dis. 2019 Apr 1;1865(4):797-809
pubmed: 30290272
J Pineal Res. 2021 Jan;70(1):e12686
pubmed: 32730639
J Biol Chem. 2015 Apr 24;290(17):10981-93
pubmed: 25759382
Circ Res. 2011 Apr 1;108(7):837-46
pubmed: 21311045
Curr Cardiol Rev. 2018 Mar 14;14(1):53-59
pubmed: 29332590
Antioxidants (Basel). 2020 Sep 14;9(9):
pubmed: 32937950
Circ Res. 2017 Aug 18;121(5):564-574
pubmed: 28684630
Biochem Biophys Rep. 2016 Feb 27;6:54-62
pubmed: 28955862
Circulation. 2021 Feb 23;143(8):e254-e743
pubmed: 33501848
Cardiovasc Res. 2015 Jul 1;107(1):56-65
pubmed: 25916824
Sci Rep. 2017 Nov 7;7(1):14747
pubmed: 29116107
Circulation. 2004 Apr 6;109(13):1674-9
pubmed: 14981003
Cardiovasc Pathol. 2016 Mar-Apr;25(2):103-12
pubmed: 26764143
Biochem Biophys Res Commun. 2018 Nov 2;505(3):898-904
pubmed: 30309657